摘要
目的探讨为终末期糖尿病肾病(ESDN)患者进行血液透析治疗临床效果。方法选取该院于2011年6月—2013年6月期间所收治的30例终末期糖尿病肾病患者作为本次研究的对象,根据治疗结果将他们分为ESDN死亡组和ESDN存活组,比较两组尿素氮(BUN)、肌酐(CR)情况。结果本组研究对象中有6例患者在一年之内死亡,有12例患者在两年内死亡,即ESDN死亡组共计18例,分别包括3例患者死于感染性并发症,有7例患者死于心力衰竭,有8例患者死于脑出血。从两组尿素氮(BUN)、肌酐(CR)情况来看,ESDN存活组患者的初检BUN水平较低,但与死亡组比较差异无统计学意义(P>0.05),而CR水平较高,与死亡组差异具有统计学意义(P<0.05)。结论及时有效的血液透析治疗对于挽救终末期糖尿病肾病患者生命具有重要意义,但在血液透析治疗过程中应密切观察各项指标变化情况,以确保患者在最佳状态下接受治疗,减少死亡情况的发生。
Objective To observe the clinical effect of hemodialysis in patients with end-stage diabetic nephropathy （ES- DN）. Methods 30 patients with end-stage diabetic nephropathy treated in our hospital from 2011 June to were selected as the object of this study. According to the results of treatment, they were divided into ESDN group and ESDN survival group, compared with two groups of urea nitrogen （BUN）＇and ereatinine （CR）. Results In this group of patients, 6 patients died within a year. 12 patients died within two years, that is, 18 patients died of infectious complications, 8 patients died of heart failure, 3 cases died of cerebral hemorrhage in 7 patients. From the two groups of urea nitrogen （BUN）, creatinine （CR）, the ESDN level of the BUN survival group was lower, but the difference was not statistically significant （P〉0.05）, while the CR level was higher, and the difference was significant （P〈0.05）. Conclusion prompt and effective hemodialysis treatment for the patients with end-stage diabetic nephropathy has important significance, but in the process of hemodialysis treatment should he closely observed the changes of the indicators, to ensure that patients in the best condition to receive treatment, reduce the incidence of death.
出处
《糖尿病新世界》
2015年第22期122-124,共3页
Diabetes New World Magazine
关键词
终末期糖尿病肾病
血液透析
临床观察
End stage diabetic nephropathy
Hemodialysis
Clinical observation
